Interplay: The Essential Role between INSM1 and N-Myc in Aggressive Neuroblastoma

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Neuroblastoma (NB) is an aggressive childhood cancer often linked to MYCN amplification and elevated N-Myc expression.
• N-Myc acts as an oncogenic driver, promoting abnormal proliferation and inhibiting apoptosis in sympathoadrenal precursor cells, leading to NB development.
• Insulinoma-associated-1 (INSM1), a zinc-finger transcription factor, is a critical biomarker for NB, essential for tumor growth and sympathoadrenal cell differentiation.

Purpose of the Study:

• To investigate the functional relationship between N-Myc and INSM1 in neuroblastoma.
• To evaluate INSM1 as a diagnostic and prognostic biomarker for NB progression.
• To explore the INSM1/N-Myc signaling axis as a therapeutic target for NB.

Main Methods:

• Analysis of N-Myc's activation of INSM1 promoter activity.
• Assessment of INSM1's effect on N-Myc stability via AKT phosphorylation.
• Evaluation of INSM1's role in NB cell proliferation through ectopic expression and knockdown studies.
• Clinical pathological and bioinformatics analysis of INSM1 expression in NB patients.

Main Results:

• N-Myc directly activates INSM1 expression through the INSM1 proximal promoter.
• INSM1 enhances N-Myc stability by promoting AKT phosphorylation.
• Ectopic INSM1 expression stimulates NB tumor growth, while INSM1 knockdown inhibits proliferation.
• INSM1 demonstrates strong diagnostic and prognostic value in NB, with significant clinical relevance observed in INSM1/N-Myc co-expression.

Conclusions:

• The interplay between INSM1 and N-Myc is crucial for neuroblastoma development and progression.
• INSM1 serves as a potent biomarker for NB diagnosis and prognosis.
• Targeting the INSM1/N-Myc signaling axis represents a viable therapeutic strategy for neuroblastoma treatment.